Argus Upgrades Herbalife to Buy, Sees Growth Ahead
Argus upgrades Herbalife to Buy with a $15 target, citing strong Q3 results, improved EPS forecasts, and new products driving 2025 revenue growth.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
Argus upgrades Herbalife to Buy with a $15 target, citing strong Q3 results, improved EPS forecasts, and new products driving 2025 revenue growth.
China stops ByteDance from using Nvidia chips, pushing firms to adopt homegrown AI processors as Beijing ramps up tech self-sufficiency.
Robinhood is launching a new futures and derivatives exchange and clearinghouse—powered by a joint venture with Susquehanna and enhanced by the acquisition of MIAXdx—to expand and innovate its fast-growing Prediction Markets.
Workday reports Q3 2025 earnings with revenue beating estimates but cautious Q4 guidance sends shares down 6% in premarket trading amid demand concerns.
Deere forecasts fiscal 2026 net income of $4-4.75B, below estimates. Q4 profit drops to $1.06B as tariffs and weak crop prices pressure the farm equipment maker.
Petco boosts full-year earnings forecast to $395-397M as Q3 results beat expectations. Stock jumps 9% on CEO Anderson's successful transformation strategy.